MedTrace Logo

Reliability and Validity Study for SWE of Shoulder Muscles in Persons After Stroke.

NCT04581551 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2022-12-14

No results posted yet for this study

Summary

This study aims

1. To examine the reliability of SWE assessment in the shoulder muscles of persons after a stroke.
2. To assess if differentiation can be made between the hemiplegic (HP) and non-hemiplegic (NHP) side and between stroke patients and matched healthy volunteers (discriminative validity).
3. To assess if an immediate effect on the pectoralis major and minor can be measured after applying transversal stretch technique to the pectoralis major muscles (response validity).

Conditions

Interventions

PROCEDURE

SWE assessor 1

SWE for 6 shoulder muscles will be performed. * m. supraspinatus * m. infraspinatus * m. rhomboideus major * m. deltoideus * m. pectoralis major * m. pectoralis minor

PROCEDURE

SWE assessor 2

SWE for 6 shoulder muscles will be performed. * m. supraspinatus * m. infraspinatus * m. rhomboideus major * m. deltoideus * m. pectoralis major * m. pectoralis minor

PROCEDURE

Stretch intervention

Transversal stretch of pectoralis major muscle on the hemiplegic side.

PROCEDURE

No stretch intervention

Passive mobilisation of the hemiplegic hand.

Sponsors & Collaborators

  • University Ghent

    collaborator OTHER

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Annelies Maenhout, Prof · University Ghent

  • Kristine Oostra, Prof · University Hospital, Ghent

  • Dirk Cambier, Prof · University Ghent

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-05
Primary Completion
2021-09-27
Completion
2021-09-27

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04581551 on ClinicalTrials.gov